Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 14,605-14,616 of 23,847
Behavioral study icon
TerminatedEUCTR 2010-023369-23

Safety study of SAFETY AND TOLERABILITY AND TO EXPLORE THE POTENTIAL THERAPEUTIC EFFICACY OF A NOVEL GLUTAMATE MODULATOR in Schizophrenia

This study was terminated in Belgium, in Germany, in Austria, .... It is testing SAFETY AND TOLERABILITY AND TO EXPLORE THE POTENTIAL THERAPEUTIC EFFICACY OF A NOVEL GLUTAMATE MODULATOR for Schizophrenia.

In Germany
SchizophreniaOther
Countries
Belgium, Germany, Austria, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Other study type icon
CompletedNCT04779632

Fish Oil Affects Cognition and ADHD Symptoms in Adults With Autism Spectrum Disorder

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Copenhagen
ADHDOtherFrom 18 Years to 45 Years
Countries
Denmark
Sponsor
University of Copenhagen
Condition
ADHD
Behavioral study icon
Active Not RecruitingNCT04541563

Fisher Wallace Neurostimulation & Depression Study

This study is looking at whether Fisher Wallace Cranial Electrotherapy Stimulator Device can help people with depression. Participants take part in Fisher Wallace Cranial Electrotherapy Stimulator Device and complete follow-up assessments.

In New York
DepressionBehavioralOver 21 Years
Countries
United States
Sponsor
ProofPilot
Condition
Depression
Behavioral study icon
CompletedNCT04239612

Fitforlife- Exercise in Care of Psychosis

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In Stockholm
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Sweden
Sponsor
Karolinska Institutet
Condition
Schizophrenia
Drug study icon
CompletedNCT01190254

Asenapine for schizophrenia

This study is completed. It is testing asenapine for schizophrenia.

Location not clearly listed
SchizophreniaDrugFrom 12 Years to 17 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Drug study icon
CompletedNCT02188121

Fixed Dose Intervention study of New England Enhancing Survival in SMI Patients

This study exists to understand how the medication New holds up over time after the earliest research stage. Researchers are trying to understand what helps the medication New stay useful, realistic, and easier to follow over time.

In Belmont
Schizophrenia, Depression, ...DrugFrom 18 Years to 89 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia, Depression, ...
Drug study icon
CompletedNCT00764478

Asenapine for Bipolarity

This study is completed. It is testing asenapine for Bipolarity.

Location not clearly listed
BipolarityDrugOver 18 Years
Countries
Sponsor
Organon and Co
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.